Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 1/2019

01-01-2019 | Brief Communication

Sleeve Gastrectomy: You Might Lose your Liver!

Authors: J. Danion, L. Genser, O. Scatton

Published in: Obesity Surgery | Issue 1/2019

Login to get access

Abstract

Sleeve gastrectomy (SG) is currently the most popular bariatric procedure. Portomesenteric venous thrombosis (PVT) is a feared and increasingly reported complication. Herein, we describe the history of a patient who developed a post-operative PVT after SG, aggravated with refractory ascites, and finally required orthotopic liver transplantation (LT). Acquired thrombophilia-anti-cardiolipin syndrome was present. As SG expands worldwide, this first case of LT for PVT following SG may warrant a systematic screening for prothrombotic condition and information on the possible consequences of PVT prior to bariatric surgery.
Literature
1.
Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219–34.CrossRefPubMed
2.
Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity. JAMA. 2018;319:241–14.CrossRefPubMedPubMedCentral
3.
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity. JAMA. 2018;319:255–11.CrossRefPubMedPubMedCentral
4.
Zellmer JD, Mathiason MA, Kallies KJ, Kothari SN. Is laparoscopic sleeve gastrectomy a lower risk bariatric procedure compared to laparoscopic Roux-en-Y gastric bypass? A meta-analysis. Am J Surg. 2014;208:903–10
5.
Tan SBM, Hopkins G, Greenslade J, et al. Portomesenteric vein thrombosis in sleeve gastrectomy: a 10-year review. Surg Obes Relat Dis. 2018;14:1–5.CrossRef
6.
Moon RC, Ghanem M, Teixeira AF, et al. Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study. Surg Obes Relat Dis. 2018;14:478–83.CrossRefPubMed
7.
Alshreadah S, Alotaibi R, Aldabaeab A, et al. Thrombosis of the spleno-mesentiric portal axis following laparoscopic sleeve gastrectomy: a rare case report. Int J Surg Case Rep. 2018;43:29–31.CrossRefPubMedPubMedCentral
8.
Plessier A, Rautou P-E, Valla D-C. Management of hepatic vascular diseases. J Hepatol. 2012;56:S25–38.CrossRefPubMed
9.
Meijer B, Simsek M, Blokzijl H, et al. Nodular regenerative hyperplasia rarely leads to liver transplantation: a 20-year cohort study in all Dutch liver transplant units. United European Gastroenterol J. 2016;5:658–67.CrossRefPubMedPubMedCentral
10.
Regnault D, d’Alteroche L, Nicolas C, Dujardin F, Ayoub J, Perarnau JM. Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension. Eur J Gastroenterol Hepatol. 2018;30:557–562.
11.
Shoar S, Saber AA, Rubenstein R, Safari S, Brethauer SA, Al-Thani H, et al. Portomesentric and splenic vein thrombosis (PMSVT) after bariatric surgery: a systematic review of 110 patients. Surg Obes Relat Dis. 2018;14:47–59.
12.
Nielsen AW. Perioperative bleeding and blood transfusion are major risk factors for venous thromboembolism following bariatric surgery. Surg Endosc. 2018;32:2488–2495.
13.
Thereaux J, Lesuffleur T, Czernichow S, et al. To what extent does posthospital discharge chemoprophylaxis prevent venous thromboembolism after bariatric surgery? Ann Surg. 2018;267:727–33.CrossRefPubMed
14.
Sharma G, Hanipah ZN, Aminian A, Punchai S, Bucak E, Schauer PR, et al. Bariatric surgery in patients on chronic anticoagulation therapy. Obes Surg. 2018;28:2225–223
15.
Bhat R, Bhadoria A, Maiwall R, et al. Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: need for a new classification. Saudi J Gastroenterol. 2015;21:129–10.CrossRefPubMedPubMedCentral
16.
Rodríguez-Castro KI, Porte RJ, Nadal E, et al. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation. Transplantation. 2012;94:1145–53.CrossRefPubMed
Metadata
Title
Sleeve Gastrectomy: You Might Lose your Liver!
Authors
J. Danion
L. Genser
O. Scatton
Publication date
01-01-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 1/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3563-7

Other articles of this Issue 1/2019

Obesity Surgery 1/2019 Go to the issue

Letter to the Editor

Pancreatic Tail Bleeding and Leakage After Sleeve Gastrectomy in a Patient with High Body Mass Index: a Case Report

Original Contributions

Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy

Original Contributions

EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial

Original Contributions

Seven-Year Outcomes of Laproscopic Sleeve Gastectomy in Indian Patients with Different Classes of Obesity

Original Contributions

Analyzing the Impact of Bariatric Surgery in Kidney Function: a 2-Year Observational Study

Letter to the Editor

What Is the Current Evidence to Define the Length of the Alimentary Limb in the Laparoscopic Gastric Bypass Technique?